Cargando…

Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion

BACKGROUND: Nerve growth factor (NGF), glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) all play important roles in the development of the peripheral sensory nervous system. Additionally, these growth factors are proposed to modulate the properties of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Theodore J, Louria, Michael D, Candelario-Soto, Damaries, Dussor, Gregory O, Jeske, Nathanial A, Patwardhan, Amol M, Diogenes, Anibal, Trott, Amanda A, Hargreaves, Kenneth M, Flores, Christopher M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548274/
https://www.ncbi.nlm.nih.gov/pubmed/15667652
http://dx.doi.org/10.1186/1471-2202-6-4
_version_ 1782122330314506240
author Price, Theodore J
Louria, Michael D
Candelario-Soto, Damaries
Dussor, Gregory O
Jeske, Nathanial A
Patwardhan, Amol M
Diogenes, Anibal
Trott, Amanda A
Hargreaves, Kenneth M
Flores, Christopher M
author_facet Price, Theodore J
Louria, Michael D
Candelario-Soto, Damaries
Dussor, Gregory O
Jeske, Nathanial A
Patwardhan, Amol M
Diogenes, Anibal
Trott, Amanda A
Hargreaves, Kenneth M
Flores, Christopher M
author_sort Price, Theodore J
collection PubMed
description BACKGROUND: Nerve growth factor (NGF), glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) all play important roles in the development of the peripheral sensory nervous system. Additionally, these growth factors are proposed to modulate the properties of the sensory system in the adult under pathological conditions brought about by nerve injury or inflammation. We have examined the effects of NGF, GDNF and BDNF on adult rat trigeminal ganglion (TG) neurons in culture to gain a better understanding of how these growth factors alter the cytochemical and functional phenotype of these neurons, with special attention to properties associated with nociception. RESULTS: Compared with no growth factor controls, GDNF, at 1 and 100 ng/ml, significantly increased by nearly 100% the number of neurons in culture at 5 days post-plating. A significant, positive, linear trend of increasing neuron number as a function of BDNF concentration was observed, also peaking at nearly 100%. NGF treatment was without effect. Chronic treatment with NGF and GDNF significantly and concentration-dependently increased 100 nM capsaicin (CAP)-evoked calcitonin gene-related peptide (CGRP) release, reaching approximately 300% at the highest concentration tested (100 ng/ml). Also, NGF and GDNF each augmented anandamide (AEA)- and arachidonyl-2-chloroethylamide (ACEA)-evoked CGRP release, while BDNF was without effect. Utilizing immunohistochemistry to account for the proportions of TRPV1- or CGRP-positive neurons under each growth factor treatment condition and then standardizing evoked CGRP release to these proportions, we observed that NGF was much more effective in enhancing CAP- and 50 mM K(+)-evoked CGRP release than was GDNF. Furthermore, NGF and GDNF each altered the concentration-response function for CAP- and AEA-evoked CGRP release, increasing the E(max )without altering the EC(50 )for either compound. CONCLUSIONS: Taken together, our results illustrate that NGF, GDNF and BDNF differentially alter TG sensory neuron survival, neurochemical properties and TRPV1-mediated neuropeptide release in culture. In particular, our findings suggest that GDNF and NGF differentially modulate TRPV1-mediated neuropeptide secretion sensitivity, with NGF having a much greater effect on a per neuron basis than GDNF. These findings are discussed in relation to possible therapeutic roles for growth factors or their modulators in pathological pain states, especially as these relate to the trigeminal system.
format Text
id pubmed-548274
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5482742005-02-06 Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion Price, Theodore J Louria, Michael D Candelario-Soto, Damaries Dussor, Gregory O Jeske, Nathanial A Patwardhan, Amol M Diogenes, Anibal Trott, Amanda A Hargreaves, Kenneth M Flores, Christopher M BMC Neurosci Research Article BACKGROUND: Nerve growth factor (NGF), glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) all play important roles in the development of the peripheral sensory nervous system. Additionally, these growth factors are proposed to modulate the properties of the sensory system in the adult under pathological conditions brought about by nerve injury or inflammation. We have examined the effects of NGF, GDNF and BDNF on adult rat trigeminal ganglion (TG) neurons in culture to gain a better understanding of how these growth factors alter the cytochemical and functional phenotype of these neurons, with special attention to properties associated with nociception. RESULTS: Compared with no growth factor controls, GDNF, at 1 and 100 ng/ml, significantly increased by nearly 100% the number of neurons in culture at 5 days post-plating. A significant, positive, linear trend of increasing neuron number as a function of BDNF concentration was observed, also peaking at nearly 100%. NGF treatment was without effect. Chronic treatment with NGF and GDNF significantly and concentration-dependently increased 100 nM capsaicin (CAP)-evoked calcitonin gene-related peptide (CGRP) release, reaching approximately 300% at the highest concentration tested (100 ng/ml). Also, NGF and GDNF each augmented anandamide (AEA)- and arachidonyl-2-chloroethylamide (ACEA)-evoked CGRP release, while BDNF was without effect. Utilizing immunohistochemistry to account for the proportions of TRPV1- or CGRP-positive neurons under each growth factor treatment condition and then standardizing evoked CGRP release to these proportions, we observed that NGF was much more effective in enhancing CAP- and 50 mM K(+)-evoked CGRP release than was GDNF. Furthermore, NGF and GDNF each altered the concentration-response function for CAP- and AEA-evoked CGRP release, increasing the E(max )without altering the EC(50 )for either compound. CONCLUSIONS: Taken together, our results illustrate that NGF, GDNF and BDNF differentially alter TG sensory neuron survival, neurochemical properties and TRPV1-mediated neuropeptide release in culture. In particular, our findings suggest that GDNF and NGF differentially modulate TRPV1-mediated neuropeptide secretion sensitivity, with NGF having a much greater effect on a per neuron basis than GDNF. These findings are discussed in relation to possible therapeutic roles for growth factors or their modulators in pathological pain states, especially as these relate to the trigeminal system. BioMed Central 2005-01-24 /pmc/articles/PMC548274/ /pubmed/15667652 http://dx.doi.org/10.1186/1471-2202-6-4 Text en Copyright © 2005 Price et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Price, Theodore J
Louria, Michael D
Candelario-Soto, Damaries
Dussor, Gregory O
Jeske, Nathanial A
Patwardhan, Amol M
Diogenes, Anibal
Trott, Amanda A
Hargreaves, Kenneth M
Flores, Christopher M
Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion
title Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion
title_full Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion
title_fullStr Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion
title_full_unstemmed Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion
title_short Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion
title_sort treatment of trigeminal ganglion neurons in vitro with ngf, gdnf or bdnf: effects on neuronal survival, neurochemical properties and trpv1-mediated neuropeptide secretion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548274/
https://www.ncbi.nlm.nih.gov/pubmed/15667652
http://dx.doi.org/10.1186/1471-2202-6-4
work_keys_str_mv AT pricetheodorej treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT louriamichaeld treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT candelariosotodamaries treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT dussorgregoryo treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT jeskenathaniala treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT patwardhanamolm treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT diogenesanibal treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT trottamandaa treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT hargreaveskennethm treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion
AT floreschristopherm treatmentoftrigeminalganglionneuronsinvitrowithngfgdnforbdnfeffectsonneuronalsurvivalneurochemicalpropertiesandtrpv1mediatedneuropeptidesecretion